Baseline clinical characteristics
| Variable . | Whole cohort analyzed for MRD (n = 259) . | MCL Younger (n = 160) . | MCL Elderly (n = 99) . |
|---|---|---|---|
| Median age, y (range) | 61 (33-81) | 55 (33-65) | 70 (60-81) |
| Sex male, % | 77 | 81 | 71 |
| Stage, % | |||
| 2 | 2 | 1 | 4 |
| 3 | 14 | 15 | 12 |
| 4 | 84 | 84 | 84 |
| B-symptoms, % | 39 | 39 | 39 |
| LDH, elevated, % | 39 | 38 | 41 |
| Extranodal > 1, % | 34 | 37 | 29 |
| Bone marrow, % | 81 | 83 | 79 |
| MIPI risk, % | |||
| Low | 43 | 65 | 8 |
| Intermediate | 34 | 23 | 52 |
| High | 23 | 12 | 40 |
| Variable . | Whole cohort analyzed for MRD (n = 259) . | MCL Younger (n = 160) . | MCL Elderly (n = 99) . |
|---|---|---|---|
| Median age, y (range) | 61 (33-81) | 55 (33-65) | 70 (60-81) |
| Sex male, % | 77 | 81 | 71 |
| Stage, % | |||
| 2 | 2 | 1 | 4 |
| 3 | 14 | 15 | 12 |
| 4 | 84 | 84 | 84 |
| B-symptoms, % | 39 | 39 | 39 |
| LDH, elevated, % | 39 | 38 | 41 |
| Extranodal > 1, % | 34 | 37 | 29 |
| Bone marrow, % | 81 | 83 | 79 |
| MIPI risk, % | |||
| Low | 43 | 65 | 8 |
| Intermediate | 34 | 23 | 52 |
| High | 23 | 12 | 40 |
MRD indicates minimal residual disease; MCL, mantle cell lymphoma; LDH, lactate dehydrogenase; and MIPI, MCL International Prognostic Index.